8 completed. 8 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Completed 8 |
| Phase 2 | 3 | Completed 3 |
Follow Drug Abuse: new trials by email Literature Review of Drug Abuse trials Research Report on Drug Abuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Medication Treatment for Opioid Use Disorder in Expectant Mothers Buprenorphine Injection, Buprenorphine Sublingual Product - Opioid-Related Disorders, Drug Addiction | Phase 3 | Completed | T. John Winhusen, PhD | 140 | 2020-07-21 | 2026-06-04 |
| Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital Naloxone, intranasal, placebo, intranasal, Naloxone, intramuscular - Overdose, Drug Abuse | Phase 3 | Completed | Norwegian University of Science and Technology | 286 | 2018-05-15 | 2020-10-08 |
| Multidisciplinary Approach to Reduce Injury and Substance Abuse Brief advice, Brief Intervention plus Booster, Brief Intervention - Drug Abuse | Phase 3 | Completed | University of Texas at Austin | 417 | 2010-01-01 | 2015-11-25 |
| Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use Standard Brief Intervention, Enhanced Brief Intervention, Control: Information and Feedback - Drug Usage, Drug Abuse | Phase 3 | Completed | Boston Medical Center | 589 | 2009-04-01 | 2014-10-02 |
| Stimulant Abuser Groups to Engage in 12-Step STAGE-12, Treatment as Usual - Drug Abuse | Phase 3 | Completed | University of Washington | 471 | 2008-01-01 | 2016-12-05 |
| Adventure: Teacher Delivered Personality-targeted Interventions for Substance Misuse Personality-targeted interventions - Alcohol Abuse, Drug Abuse | Phase 2 / Phase 3 | Completed | King's College London | 3190 | 2007-05-01 | 2011-06-27 |
| Prometa Pharmacotherapy for Methamphetamine Dependence Prometa, Placebo - Drug Abuse, Drug Dependence | Phase 2 / Phase 3 | Completed | University of California, Los Angeles | 120 | 2006-01-01 | 2016-01-22 |
| Personality-targeted Interventions for Adolescent Alcohol Misuse PRE-Venture: Personality Risk Education - Alcohol Abuse, Drug Abuse | Phase 2 / Phase 3 | Completed | King's College London | 710 | 2003-11-01 | 2011-06-27 |
Substance-Related Disorders (8) · Alcoholism (2) · Conduct Disorder (2) · Depression (2) · Panic Disorder (2) · Antisocial Personality Disorder (1) · Anxiety Disorders (1) · Behavior, Addictive (1) · Binge Drinking (1) · Drug Overdose (1) · Neonatal Abstinence Syndrome (1) · Opioid-Related Disorders (1) · Patient Acceptance of Health Care (1) · Wounds and Injuries (1)
Chemically-Induced Disorders (8) · Mental Disorders (8) · Behavior (3) · Alcohol-Related Disorders (2) · Attention Deficit and Disruptive Behavior Disorders (2) · Behavioral Symptoms (2) · Neurodevelopmental Disorders (2) · Alcohol Drinking (1) · Anxiety Disorders (1) · Compulsive Behavior (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Drinking Behavior (1) · Drug Misuse (1) · Health Behavior (1) · Impulsive Behavior (1)
Buprenorphine (1) · Buprenorphine, Naloxone Drug Combination (1) · Crisis Intervention (1) · Immunization, Secondary (1) · Injections, Intramuscular (1) · Naloxone (1) · Therapeutics (1)
King's College London (2) · Boston Medical Center (1) · Norwegian University of Science and Technology (1) · T. John Winhusen, PhD (1) · University of California, Los Angeles (1) · University of Texas at Austin (1) · University of Washington (1)
United States (5) · United Kingdom (2) · Norway (1)
Arne K Skulberg, MD PhD (1) · Craig A Field, PhD (1) · Dennis Daley, Ph.D. (1) · Dennis Donovan, Ph.D. (1) · Mary M Velasquez, PhD (1) · Patricia J Conrod, PhD (1) · Patricia J. Conrod, Ph.D. (1) · Richard Saitz, MD (1) · T. John Winhusen, PhD (1) · Walter Ling, M.D. (1)
PMID 20732631, PMID 20048226, PMID 20869813, PMID 22082089, PMID 22657748, PMID 23344135, PMID 25096690, PMID 26011508, PMID 26809204, PMID 26881449, PMID 30865304, PMID 33184084, PMID 35137493, PMID 37023858, PMID 39105509, PMID 40643178, PMID 41015387, PMID 41429292, PMID 41837971
2016 (1), R01DA025068 (1), R01DA026088 (1), U10DA013714 (1), UG1DA013732 (1)